| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 0.958 | 120 | 0 | 1993 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
disease | 0.100 | None | 0.962 | 79 | 0 | 1994 | 2020 | ||||||||
|
E2F transcription factor 1 | 0.441 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.953 | 43 | 0 | 1996 | 2020 | ||||||||
|
esterase D | 0.656 | 0.615 | 5.4E-07 |
|
disease | 0.100 | None | 0.947 | 38 | 0 | 1980 | 2009 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 0.972 | 36 | 0 | 1995 | 2019 | |||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.100 | None | 0.969 | 32 | 0 | 1984 | 2019 | ||||||||
|
trichoplein keratin filament binding | 0.570 | 0.692 | 1.8E-16 |
|
disease | 0.100 | None | 0.968 | 31 | 0 | 1992 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.963 | 27 | 0 | 2006 | 2019 | ||||||||
|
RB transcriptional corepressor like 1 | 0.666 | 0.385 | 2.9E-12 |
|
disease | 0.100 | None | 1.000 | 25 | 0 | 1992 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.917 | 24 | 0 | 1991 | 2019 | ||||||||
|
RAB3 GTPase activating protein catalytic subunit 1 | 0.566 | 0.692 | 1.5E-07 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 1994 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2007 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2007 | 2019 | ||||||||
|
nucleolar and coiled-body phosphoprotein 1 | 0.641 | 0.615 | 1.0E-04 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 1994 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2007 | 2019 | ||||||||
|
cyclin dependent kinase 2 | 0.456 | 0.692 | 0.61 |
|
disease | 0.100 | None | 0.952 | 21 | 0 | 1996 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1996 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 2000 | 2019 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2000 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2006 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1994 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 1992 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1996 | 2018 | ||||||||
|
PR/SET domain 2 | 0.545 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1996 | 2017 | ||||||||
|
proteasome 26S subunit, non-ATPase 9 | 0.435 | 0.846 | 4.9E-06 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2001 | 2018 |